Gene expression and protein abundance of clinically relevant phase I & II enzymes in the human intestine

被引：0
|
作者：
Busch, D. [1 ]
Drozdzik, M. [2 ]
Siegmund, W. [1 ]
Oswald, S. [1 ]
机构：
[1] Univ Med Greifswald, Clin Pharmacol, Greifswald, Germany
[2] Pomeranian Med Univ, Dept Expt & Clin Pharmacol, Szczecin, Poland
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2015年 / 388卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
244
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [31] Site-specific miRNA expression affects transporter protein abundance along the human intestine
    Bruckmueller, H.
    Martin, P.
    Kaehler, M.
    Haenisch, S.
    Drozdzik, M.
    Oswald, S.
    Siegmund, W.
    Cascorbi, I.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S61 - S62
  • [32] Expression of human phase II enzymes in chimeric mice with humanized liver
    Katoh, M
    Matsui, T
    Okumura, H
    Nakajima, M
    Nishimura, M
    Naito, S
    Tateno, C
    Yoshizato, K
    Yokoi, T
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (09) : 1333 - 1340
  • [33] Gene Expression and Protein Abundance of Nuclear Receptors in Human Intestine and Liver: A New Application for Mass Spectrometry-Based Targeted Proteomics
    Wenzel, Christoph
    Goedtke, Lisa
    Reichstein, Anne
    Keiser, Markus
    Busch, Diana
    Drozdzik, Marek
    Oswald, Stefan
    MOLECULES, 2022, 27 (14):
  • [34] QUANTITATIVE PROTEOMICS OF CLINICALLY RELEVANT DRUG-METABOLIZING ENZYMES AND DRUG TRANSPORTERS AND THEIR INTER-CORRELATIONS IN THE HUMAN SMALL INTESTINE.
    Al-Majdoub, Z.
    Couto, N.
    Achour, B.
    Harwood, M.
    Barber, J.
    Rostami-Hodjegan, A.
    Warhurst, G.
    Carlson, G.
    Gibson, S.
    Davies, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S46 - S46
  • [35] Zearalenone Induces Endoplasmic Reticulum Stress and Modulates the Expression of Phase I/II Enzymes in Human Liver Cells
    Yoon, Jee Eun
    Lee, Kwang Yong
    Seok, Jin Sil
    Cheng, Wei Nee
    Kwon, Hyuk Cheol
    Jeong, Chang Hee
    Han, Sung Gu
    TOXINS, 2020, 12 (01)
  • [36] Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes
    Nishimura, Masuhiro
    Naito, Shinsaku
    DRUG METABOLISM AND PHARMACOKINETICS, 2006, 21 (05) : 357 - 374
  • [37] Effect of dietary protein on hepatic and extrahepatic phase I and phase II drug metabolizing enzymes
    Baijal, PK
    Fitzpatrick, DW
    TOXICOLOGY LETTERS, 1996, 89 (02) : 99 - 106
  • [38] Site-specific MIRNA expression influences/Controls transporter protein abundance along the human intestine
    Martin, P.
    Bruckmueller, H.
    Cascorbi, I
    Drozdzik, M.
    Oswald, S.
    Haenisch, S.
    Siegmund, W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S22 - S22
  • [39] Diallyl sulfide antagonizes PhIP induced alterations in the expression of phase I and phase II metabolizing enzymes in human breast epithelial cells
    Wilson, CL
    Aboyade-Cole, AA
    Darling-Reed, S
    Thomas, RD
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2687S - 2688S
  • [40] IN-VIVO INDUCTION OF HUMAN PHASE-I AND PHASE-II ENZYMES BY DIET
    KALL, MA
    VANG, O
    ANDERSEN, O
    CLAUSEN, J
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 197 - 197
12345